Nice- happy windsurfing! “ INSERM’s Kieny s
Post# of 148281
“ INSERM’s Kieny says it’s an “enormous” waste for EU countries to invest in remdesivir based on the idea that it might help a small subset of patients. “You can always say, 'OK, now, if I disaggregate the population and if I take only those who have a blue eye and a wooden leg, maybe this is very effective,” she says.”